Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

VJVirtual | Giving rare diseases the spotlight

Naveen Pemmaraju • 15 May 2020
General

Naveen Pemmaraju, MD, of the MD Anderson Cancer Center, Houston, TX, highlights the importance of raising awareness for rare diseases and underlines the value of molecular subtyping in hematological malignancies to enable the development of targeted therapies as well as provide personalised medicine to rare disease patients. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

More from Naveen Pemmaraju

BPDCN: unmet needs, CD123-targeted therapies and novel targets
15:50
BPDCN: unmet needs, CD123-targeted therapies and novel targets
Naveen Pemmaraju • 19 Sep 2026
Novel agents and approaches being explored in second-line myelofibrosis
14:29
Novel agents and approaches being explored in second-line myelofibrosis
Claire Harrison et al. • 2 Oct 2026
Evolving treatment landscape in MF: JAK inhibitors, combination therapy, and novel agents
1:39
Evolving treatment landscape in MF: JAK inhibitors, combination therapy, and novel agents
Naveen Pemmaraju • 10 Sep 2026
Exploring JAK inhibitor-based combination strategies in myelofibrosis
1:55
Exploring JAK inhibitor-based combination strategies in myelofibrosis
Naveen Pemmaraju • 10 Sep 2026

Related Videos

The ethical challenges of AI in hematology: patient communication, trust and regulation
3:12
The ethical challenges of AI in hematology: patient communication, trust and regulation
Adrián Mosquera Orgueira • 24 Sep 2026
The future of AI in hematology: personalized medicine, opportunities and risks
2:30
The future of AI in hematology: personalized medicine, opportunities and risks
Adrián Mosquera Orgueira • 24 Sep 2026
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
5:18
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
Shyam Patel • 13 Oct 2026
The scientific and clinical implications of therapy-related CHIP in oncology
2:43
The scientific and clinical implications of therapy-related CHIP in oncology
Shyam Patel • 13 Oct 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals